Agent Capital
A biotech venture capital firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Agent Capital Information
Geographic Data
Address: 810 Memorial Drive,
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$169M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Agent Capital is a private equity firm that focuses on investing in the novel therapeutic applications.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2017 | Orbus Therapeutics | Series B | 12.5M |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 12/2018 | Entrada Therapeutics | Series A | 59M |
| 12/2017 | Aptinyx | Series B | 70M |
| 3/2021 | Pyxis Oncology | Series B | 152M |
| 3/2020 | Interius BioTherapeutics | Venture Round | 0 |
| 4/2023 | Orbital Therapeutics | Series A | 0 |
| 3/2021 | Carisma Therapeutics | Series B | 0 |
| 4/2023 | Foresight Diagnostics | Series B | 0 |
| 6/2018 | Precision BioSciences | Series B | 0 |
| 12/2021 | Cyrus Biotechnology | Series B | 0 |
| 6/2022 | Vittoria Biotherapeutics | Seed | 10M |
| 3/2022 | Affini-T Therapeutics | Venture Round | 0 |
| 3/2021 | Mediar Therapeutics | Seed Round | - |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 11/2020 | Metagenomi | Series A | 0 |
| 8/2019 | Metagenomi | Series A | 0 |
| 1/2023 | Palvella Therapeutics | Series D | 37.7M |
| 1/2021 | Dice Therapeutics | Series C | 80M |
| 11/2022 | Zenas BioPharma | Series B | 0 |
| 7/2018 | Verge Genomics | Series A | 0 |
| 12/2017 | Orchard Therapeutics | Series B | 0 |
| 1/2021 | Carisma Therapeutics | Series B | 0 |
| 12/2019 | ImCheck Therapeutics | Series B | 53.2M |
| 6/2018 | Carisma Therapeutics | Series A | 0 |
| 9/2022 | Carisma Therapeutics | Series C | 0 |
| 8/2018 | Orchard Therapeutics | Series C | 0 |
| 3/2020 | Pliant Therapeutics | Series C | 0 |
| 6/2018 | Skyhawk Therapeutics | Venture Round | 0 |
| 3/2023 | Flare Therapeutics | Series B | 0 |
| 5/2017 | Dragonfly Therapeutics | Venture Round | - |
| 7/2019 | Pyxis Oncology | Series A | 22M |
| 5/2021 | Interius BioTherapeutics | Series A | 0 |
| 7/2018 | Pliant Therapeutics | Series B | 0 |
| 5/2020 | Palvella Therapeutics | Series C | 0 |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 6/2022 | Carbon Biosciences | Series A | 0 |
| 6/2022 | Carbon Biosciences | Series A | 0 |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 3/2022 | Affini-T Therapeutics | Venture Round | 0 |
| 12/2021 | Cyrus Biotechnology | Series B | 0 |
| 8/2021 | Immunitas Therapeutics | Series B | 0 |
| 5/2021 | Interius BioTherapeutics | Series A | 0 |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 3/2021 | Pyxis Oncology | Series B | 0 |
| 3/2021 | Mediar Therapeutics | Seed Round | - |
| 3/2021 | Carisma Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
